Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cosmos Health Inc
(NQ:
COSM
)
1.220
-0.060 (-4.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,118,113
Open
1.270
Bid (Size)
1.200 (50)
Ask (Size)
1.230 (1)
Prev. Close
1.280
Today's Range
1.201 - 1.360
52wk Range
0.4677 - 2.050
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements
August 23, 2024
Via
ACCESSWIRE
Why Cosmos Health Stock Is Moving Higher Wednesday
August 21, 2024
Cosmos Health announced that it continues to hold the right to distribute mpox real-time PCR detection kits under its agreement with Virax Biolabs
Via
Benzinga
Performance
YTD
-10.95%
-10.95%
1 Month
+0.83%
+0.83%
3 Month
+74.54%
+74.54%
6 Month
+59.50%
+59.50%
1 Year
N/A
N/A
More News
Read More
Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE
August 21, 2024
Via
ACCESSWIRE
Cosmos Health Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits
August 21, 2024
Via
ACCESSWIRE
COSM Stock Earnings: Cosmos Health Reported Results for Q2 2024
August 20, 2024
Via
InvestorPlace
Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE
July 02, 2024
Via
ACCESSWIRE
Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs. H1 2023
August 20, 2024
Via
ACCESSWIRE
Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit
August 20, 2024
Via
ACCESSWIRE
Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market
August 08, 2024
Via
ACCESSWIRE
Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share
August 06, 2024
Via
ACCESSWIRE
Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar
July 25, 2024
Via
ACCESSWIRE
Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland
July 25, 2024
Via
ACCESSWIRE
Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity
July 24, 2024
Via
ACCESSWIRE
Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units
July 18, 2024
Via
ACCESSWIRE
Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule
July 18, 2024
Via
ACCESSWIRE
Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market
July 10, 2024
Via
ACCESSWIRE
Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually
July 09, 2024
Via
ACCESSWIRE
Cosmos Health Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months
July 02, 2024
Via
ACCESSWIRE
Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains
July 01, 2024
Via
ACCESSWIRE
Why Cosmos Health Stock Is Trading Higher Friday
June 28, 2024
Via
Benzinga
Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today?
June 28, 2024
Via
InvestorPlace
Why Is Nexalin Technology (NXL) Stock Down 35% Today?
June 28, 2024
Via
InvestorPlace
Why Is Cosmos Health (COSM) Stock Up 65% Today?
June 28, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 28, 2024
Via
InvestorPlace
Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units
June 27, 2024
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.